We are live on ! Find out more
EA

Emerald Advisers Portfolio holdings

AUM $3.16B
1-Year Est. Return 109.58%
This Fund
S&P 500
This Quarter Est. Return
+36.72%
1 Year Est. Return
+109.58%
3 Year Est. Return
+352.93%
5 Year Est. Return
+451.34%
10 Year Est. Return
+3,577.15%
AUM
$3.01B
AUM Growth
+$583M
Cap. Flow
-$32.3M
Cap. Flow %
-1.07%
Top 10 Hldgs %
19.61%
Holding
374
New
40
Increased
94
Reduced
116
Closed
88

Sector Composition

Rank Sector Weight
1 Healthcare 23.28%
2 Technology 20.52%
3 Consumer Discretionary 15.17%
4 Industrials 13.7%
5 Financials 8.68%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TMHC icon
51
Taylor Morrison
TMHC
$6.64B
$23.8M 0.79%
928,615
-261,645
-22% -$6.67M
VC icon
52
Visteon
VC
$2.8B
$23.6M 0.78%
187,861
+85,364
+83% +$9M
CMD
53
DELISTED
Cantel Medical Corporation
CMD
$23.1M 0.77%
292,554
+282,740
+2,881% +$16.6M
EVRI
54
DELISTED
Everi Holdings
EVRI
$22.9M 0.76%
1,660,000
-417,358
-20% -$4.53M
NVEE
55
DELISTED
NV5 Global
NVEE
$22.8M 0.76%
1,159,212
+1,924
+0.2% +$32.4K
MTH icon
56
Meritage Homes
MTH
$4.95B
$22.5M 0.75%
542,812
-269,362
-33% -$12.7M
MRTX
57
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
$22.4M 0.74%
102,046
-78,991
-44% -$17.1M
DKS icon
58
Dick's Sporting Goods
DKS
$19.5B
$22.3M 0.74%
397,323
+3,235
+0.8% +$184K
ARVN icon
59
Arvinas
ARVN
$517M
$21.9M 0.73%
+257,940
New +$8.89M
PRFT
60
DELISTED
Perficient Inc
PRFT
$21.5M 0.71%
450,197
+121,646
+37% +$5.52M
MAX icon
61
MediaAlpha
MAX
$763M
$21.3M 0.71%
+546,421
New +$21.2M
ATSG
62
DELISTED
Air Transport Services Group
ATSG
$21.2M 0.71%
677,955
+86,855
+15% +$2.54M
ALGM icon
63
Allegro MicroSystems
ALGM
$8.66B
$20.9M 0.69%
+782,478
New +$18.9M
HLI icon
64
Houlihan Lokey
HLI
$9.67B
$20.5M 0.68%
+304,420
New +$19.7M
MRCY icon
65
Mercury Systems
MRCY
$5.77B
$20.4M 0.68%
231,741
-127,482
-35% -$9.69M
STMP
66
DELISTED
Stamps.com, Inc.
STMP
$20.3M 0.67%
103,528
+27,385
+36% +$6.01M
CCOI icon
67
Cogent Communications
CCOI
$549M
$20.2M 0.67%
337,638
+29
+0% +$1.72K
EVER icon
68
EverQuote
EVER
$925M
$19.8M 0.66%
531,242
+91,926
+21% +$3.48M
DOOR
69
DELISTED
MASONITE INTERNATIONAL CORP
DOOR
$19.6M 0.65%
199,490
-412
-0.2% -$40K
TWST icon
70
Twist Bioscience
TWST
$5.84B
$19.1M 0.63%
134,847
-259,964
-66% -$28.8M
FWRD icon
71
Forward Air
FWRD
$435M
$18.8M 0.62%
+244,059
New +$16.9M
DCPH
72
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
$18.6M 0.62%
325,126
+60,495
+23% +$3.59M
WGO icon
73
Winnebago Industries
WGO
$868M
$18.3M 0.61%
305,061
+5,899
+2% +$322K
DIOD icon
74
Diodes
DIOD
$4B
$18.1M 0.6%
256,669
+79,863
+45% +$5.15M
ONT
75
Onterris Inc
ONT
$756M
$18M 0.6%
581,803
+137,236
+31% +$3.9M

Similar funds

Emerald Advisers's Q4 2020 Portfolio in Review

As of Q4 2020, Emerald Advisers held 374 positions worth $3.01B, up 24% from $2.43B the previous quarter. Its ten largest holdings account for 20% of the portfolio.

Emerald Advisers's Q4 2020 filing shows 40 new, 94 increased, 116 reduced and 88 closed positions. Its largest new stake was Ultragenyx Pharmaceutical: 226,875 shares worth $31.4M. The largest sale was Horizon Therapeutics Public Limited Company Ordinary Shares, an estimated $43.8M.

By sector, the portfolio is most concentrated in Healthcare at 23% of assets, up from 21% a quarter earlier, followed by Technology and Consumer Discretionary.

  • Emerald Advisers's largest Q4 2020 buy was Ultragenyx Pharmaceutical: 226,875 shares worth $31.4M.
  • Emerald Advisers added most to Arena Pharmaceuticals Inc in Q4 2020, an estimated $18.6M increase.
  • Emerald Advisers's biggest Q4 2020 reduction was Horizon Therapeutics Public Limited Company Ordinary Shares, cutting an estimated $43.8M.
  • Emerald Advisers fully exited Pluralsight, Inc. Class A Common Stock in Q4 2020, selling an estimated $24.1M.
  • Emerald Advisers's ten largest holdings make up 20% of its $3.01B portfolio in Q4 2020.
  • Emerald Advisers opened 40 new positions and closed 88 in Q4 2020.
  • Emerald Advisers's portfolio value rose 24% quarter-over-quarter to $3.01B.

Based on Emerald Advisers's 13F filing for Q4 2020, filed 29 Jan 2021.